Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Novartis' Ameet Nathwani Joins Sanofi

This article was originally published in Scrip

Executive Summary

Ameet Nathwani has been appointed to Sanofi's executive committee – effective May 1, 2016. Nathwani joins the company from Novartis taking the position of executive vice president, group chief medical officer. From 1994 he held senior leadership roles in research and development in Glaxo, SmithKline Beecham and GlaxoSmithKline PLC. He joined Novartis in 2004 as senior vice president and global development head of the cardiovascular and metabolic franchise and held various senior development and commercial positions over the 11 years he was there. He was appointed global head of medical affairs Novartis Pharma AG in June 2014.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst